The evidence that high expression levels of truncated BARD1 isoforms together with Vorinostat induction of miR-19a/b could represent a marker of response to Vorinostat in AML suggests the potential application of miR-19a/band truncated BARD isoform expression as markers in AML. This evidence concerns the gene BARD1 and acute myeloid leukemia.